» Authors » Smith Apisarnthanarax

Smith Apisarnthanarax

Explore the profile of Smith Apisarnthanarax including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 80
Citations 704
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dykstra M, Apisarnthanarax S, Poultsides G, Atkins K, Binder D, Olsen J, et al.
Cancer J . 2024 Jul; 30(4):280-289. PMID: 39042780
The oligometastatic disease state, defined as a cancer with 5 or fewer sites of metastasis, is a therapeutic opportunity to improve oncologic outcomes. Colorectal cancer (CRC) was among the first...
2.
Choi J, Wojcieszynski A, Amos R, Giap H, Apisarnthanarax S, Ashman J, et al.
Int J Part Ther . 2024 May; 11:100019. PMID: 38757077
Purpose: Radiotherapy delivery in the definitive management of lower gastrointestinal (LGI) tract malignancies is associated with substantial risk of acute and late gastrointestinal (GI), genitourinary, dermatologic, and hematologic toxicities. Advanced...
3.
Hotca A, Sindhu K, Lehrer E, Hartsell W, Vargas C, Tsai H, et al.
Adv Radiat Oncol . 2024 Apr; 9(5):101459. PMID: 38596455
Purpose: Treatment options for recurrent esophageal cancer (EC) previously treated with radiation therapy (RT) are limited. Reirradiation (reRT) with proton beam therapy (PBT) can offer lower toxicities by limiting doses...
4.
Yanagihara T, Tepper J, Moon A, Barry A, Molla M, Seong J, et al.
Pract Radiat Oncol . 2024 Jan; 14(2):134-145. PMID: 38244026
Purpose: External beam radiation therapy (EBRT) is a highly effective treatment in select patients with hepatocellular carcinoma (HCC). However, the Barcelona Clinic Liver Cancer system does not recommend the use...
5.
Bierma M, Goff P, Hippe D, Lachance K, Schaub S, Wallner K, et al.
Adv Radiat Oncol . 2024 Jan; 9(2):101364. PMID: 38189056
Purpose: The role of postoperative radiation therapy (PORT) in early stage Merkel cell carcinoma (MCC) is controversial. We analyzed the role of PORT in preventing local recurrences (LR) among patients...
6.
Zaki P, Chuong M, Schaub S, Lo S, Ibrahim M, Apisarnthanarax S
Technol Cancer Res Treat . 2023 Nov; 22:15330338231206335. PMID: 37908130
External beam radiation therapy (EBRT) has increasingly been utilized in the treatment of hepatocellular carcinoma (HCC) due to technological advances with positive clinical outcomes. Innovations in EBRT include improved image...
7.
Alexander N, Schaub S, Goff P, Hippe D, Park S, Lachance K, et al.
J Am Acad Dermatol . 2023 Oct; 90(2):261-268. PMID: 37778663
Background: Merkel cell carcinoma (MCC) is often treated with surgery and postoperative radiation therapy (PORT). The optimal time to initiate PORT (Time-to-PORT [ttPORT]) is unknown. Purpose: We assessed if delays...
8.
Eckstein J, Choi J, Lozano A, Ohri N, Press R, Hasan S, et al.
Adv Radiat Oncol . 2023 Jul; 8(5):101250. PMID: 37408677
Purpose: Compared with photon-based techniques, proton beam radiation therapy (PBT) may improve the therapeutic ratio of radiation therapy (RT) for locally advanced pancreatic cancer (LAPC), but available data have been...
9.
10.
Akaike T, Cahill K, Akaike G, Huynh E, Hippe D, Shinohara M, et al.
Cancers (Basel) . 2022 Dec; 14(23). PMID: 36497395
Merkel cell carcinoma (MCC), an aggressive neuroendocrine skin cancer, has a high rate (20%) of distant metastasis. Within a prospective registry of 582 patients with metastatic MCC (mMCC) diagnosed between...